Morpheus8 RF Microneedling

Morpheus8 radiofrequency microneedling by InMode combines gold-coated fractional needles (up to 7 mm depth) with bipolar RF energy to remodel collagen in the face and body. Treats wrinkles, jowl laxity, acne scars, enlarged pores, and stretch marks. Downtime is typically twenty-four to forty-eight hours. Results develop progressively over three to six months as new collagen matures.

Morpheus8 by InMode is a subdermal fractional radiofrequency microneedling platform available at the Laser & Skin Surgery Center of New York, delivered by board-certified dermatologists as part of the center's comprehensive skin rejuvenation programme. The device's 24-pin gold-coated needle array penetrates the skin at programmable depths from 0.5 mm to 7 mm, delivering bipolar RF energy precisely at the needle tip to create thermal coagulation zones in the dermis and, at greater depths, in the fibroseptal network of the subdermal adipose tissue. The depth range is what distinguishes Morpheus8 from conventional microneedling: at 1–4 mm it targets the dermis for facial collagen remodelling and scar treatment; at 4–7 mm it addresses the deeper fibroseptal tissue responsible for structural laxity and body contouring. The Burst Mode RF delivery pattern fires at three tissue depths per needle insertion in a single stamp, distributing energy across multiple dermal planes simultaneously — improving collagen remodelling efficiency without requiring multiple treatment passes. Common facial indications at the center include early jowl laxity, perioral wrinkles, acne scars (rolling, boxcar, and shallow ice pick subtypes), enlarged pores, and general skin quality improvement in patients who are not yet candidates for surgical procedures. Body applications include neck tightening, abdominal skin laxity, inner arm laxity, and stretch mark reduction. The treatment is associated with minimal epidermal disruption because the RF energy is delivered at the needle tip beneath the skin surface rather than at the skin's surface itself, allowing the epidermis to remain largely intact during the healing phase. Post-treatment downtime is typically twenty-four to forty-eight hours of redness and mild swelling, with micro-crusting at needle entry points resolving within three to five days. Results from new collagen production begin to appear at four to six weeks post-session and continue to improve through the six-month mark. A course of three sessions spaced four to six weeks apart is the recommended protocol for most patients.